Tag Archives | Policies and strategic plans

Developing Better Terms of Reference to Improve the Performance of Pharmaceutical Sector Committees: Case Studies from South Africa

In South Africa, there are numerous governance structures that make crucial decisions about selection, procurement, distribution, and use of medicines, diagnostics, and other pharmaceutical products. A challenge commonly encountered is that critical committees either do not exist or where the committee is in place, it does not function optimally. One of the most underlying causes of poor functioning of committees is the absence of or weak terms of reference (TOR). In 2015, the Affordable Medicines Directorate (AMD) of South Africa’s National Department of Health (NDOH), requested assistance from SIAPS in strengthening the TOR of several national committees, including those involved in selection of medicines for inclusion on the National Essential Medicines List (NEML). SIAPS developed a TOR guidance document that can be used in the development or review of TOR. The purpose of this brief is to share the guidance document and the processes SIAPS and their counterparts followed to develop new and revise existing TOR for three different pharmaceutical sector committees in South Africa.

Read full story · Comments are closed

Supervision Formative Intégrée Dans les Directions Préfectorales de la Santé de Labé et de Mali

Pour lutter contre le paludisme, le Ministère de la Santé à travers le Programme national de lutte contre le paludisme (PNLP) a élaboré un plan stratégique national de troisième génération couvrant la période allant de 2013 à 2017. Il a été approuvé en février 2014 lors de la signature de l’aide-mémoire de la revue de performance du PNLP. Pour réaliser cet important volet du PSN, le PNLP, en collaboration avec ses partenaires, a élaboré en octobre 2014 et amendé en 2016 une grille nationale de supervision formative intégrée. C’est dans cette optique que s’inscrit cette supervision formative intégrée dans les directions préfectorales de la santé de Labé et de Mali du 5 au 14 août 2016, qui doit déboucher sur l’élaboration des plans de résolution des problèmes identifiés au niveau des structures.

Read full story · Comments are closed

Dissemination of DGDA’s five-year strategic plan in Bangladesh

On June 8, 2017, SIAPS disseminated the Directorate General of Drug Administration’s (DGDA) five-year Strategic Plan (2017-2021) in the presence of the Honorable Major General Mohammad Mustafizur Rahman, Director General of DGDA. The dissemination of this plan is the result of a year-long process. In March 2016, WHO engaged with various stakeholders (SIAPS, USAID, the […]

Read full story · Comments { 1 }

Developing a Central Medical Store Strategic Plan: 10 Steps for Global Health Professionals

Developing a CMS strategic plan can help align pharmaceutical supply chain objectives with overall public-sector health supply chain strategies. It can help ensure that health commodities are readily available to health facilities through an uninterrupted supply chain; minimize waste and losses; improve business and financial growth; and respond to changes in the supply chain, such as new technologies and emerging markets. In addition, advocating for and encouraging stakeholders to assess the medicine supply chain system can increase interest in generating additional technical, financial, and material resources for health care. Supply chain interventions can also contribute to improving rational medicine use and strengthening pharmaceutical regulation.

Read full story · Comments are closed